Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assigned to the intensive glycemic control arm) while offering potential benefits of unclear importance to patients. In this commentary, we review these trials, their methods, results, and implications for practice. We finish by formulating a recommended approach to the contemporary evidence-based management of patients with type 2 diabetes. Copyright by Medycyna Praktyczna, Kraków 2008.

Original languageEnglish (US)
Pages (from-to)502-507
Number of pages6
JournalPolskie Archiwum Medycyny Wewnetrznej
Volume118
Issue number9
StatePublished - 2008

Fingerprint

Type 2 Diabetes Mellitus
Safety

Keywords

  • Diabetes complications
  • Diabetes treatment
  • Evidence-based medicine
  • Glycemic control
  • Randomized trials

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{7321c2a34de148d09d48859c45d81d39,
title = "Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?",
abstract = "3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assigned to the intensive glycemic control arm) while offering potential benefits of unclear importance to patients. In this commentary, we review these trials, their methods, results, and implications for practice. We finish by formulating a recommended approach to the contemporary evidence-based management of patients with type 2 diabetes. Copyright by Medycyna Praktyczna, Krak{\'o}w 2008.",
keywords = "Diabetes complications, Diabetes treatment, Evidence-based medicine, Glycemic control, Randomized trials",
author = "Montori, {Victor Manuel}",
year = "2008",
language = "English (US)",
volume = "118",
pages = "502--507",
journal = "Polskie Archiwum Medycyny Wewnetrznej",
issn = "0032-3772",
publisher = "Medycyna Praktyczna",
number = "9",

}

TY - JOUR

T1 - Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?

AU - Montori, Victor Manuel

PY - 2008

Y1 - 2008

N2 - 3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assigned to the intensive glycemic control arm) while offering potential benefits of unclear importance to patients. In this commentary, we review these trials, their methods, results, and implications for practice. We finish by formulating a recommended approach to the contemporary evidence-based management of patients with type 2 diabetes. Copyright by Medycyna Praktyczna, Kraków 2008.

AB - 3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assigned to the intensive glycemic control arm) while offering potential benefits of unclear importance to patients. In this commentary, we review these trials, their methods, results, and implications for practice. We finish by formulating a recommended approach to the contemporary evidence-based management of patients with type 2 diabetes. Copyright by Medycyna Praktyczna, Kraków 2008.

KW - Diabetes complications

KW - Diabetes treatment

KW - Evidence-based medicine

KW - Glycemic control

KW - Randomized trials

UR - http://www.scopus.com/inward/record.url?scp=53049086705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049086705&partnerID=8YFLogxK

M3 - Article

VL - 118

SP - 502

EP - 507

JO - Polskie Archiwum Medycyny Wewnetrznej

JF - Polskie Archiwum Medycyny Wewnetrznej

SN - 0032-3772

IS - 9

ER -